{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T23:58:48Z","timestamp":1774483128975,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.nucmedbio.2017.12.006","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T13:19:07Z","timestamp":1514380747000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Imaging of isoproterenol-induced myocardial injury with  18 F labeled fluoroglucaric acid in a rat model"],"prefix":"10.1016","volume":"59","author":[{"given":"Hailey A.","family":"Houson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory N.","family":"Nkepang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andria F.","family":"Hedrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibhudutta","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0005","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0010","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1071-3581(97)90112-4","article-title":"Technetium 99m glucarate: what will be its clinical role?","volume":"4","author":"Gerson","year":"1997","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3348\/jkrs.1991.27.1.87","article-title":"Sensitivity of Tc-pyrophosphate scintigraphy in diagnosis of acute myocardial infarction","volume":"27","author":"Kim","year":"1991","journal-title":"J Korean Radiol Soc"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/01.CIR.56.2.181","article-title":"Follow-up technetium-99m stannous pyrophosphate myocardial scintigrams after acute myocardial infarction","volume":"56","author":"Olson","year":"1977","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0030","doi-asserted-by":"crossref","first-page":"218A-A","DOI":"10.1016\/0735-1097(95)92363-A","article-title":"962\u2013122 very early noninvasive imaging of acute myocardial infarcts with Tc-99m-glucarate","volume":"25","author":"Narula","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.0742-2822.2005.04032.x","article-title":"Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability","volume":"22","author":"Ghesani","year":"2005","journal-title":"Echocardiography"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2967\/jnumed.106.032789","article-title":"Clinical myocardial perfusion PET\/CT","volume":"48","author":"Di Carli","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0045","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2012.11.022","article-title":"Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography","volume":"61","author":"Berman","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0050","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5935\/1678-9741.20110024","article-title":"Experimental model of myocardial infarction induced by isoproterenol in rats","volume":"26","author":"Lobo Filho","year":"2011","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0055","first-page":"369","article-title":"Effect of alpha-tocopherol on lipid peroxidation in isoproterenol induced myocardial infarction in rats","volume":"41","author":"Ithayarasi","year":"1997","journal-title":"Indian J Physiol Pharmacol"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0008-6215(01)00231-2","article-title":"Facile nitroxide-mediated oxidations of D-glucose to D-glucaric acid","volume":"336","author":"Merbouh","year":"2001","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2009.08.097","article-title":"Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation","volume":"389","author":"Wang","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0070","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0075","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1161\/CIRCULATIONAHA.107.182882","article-title":"National Academy of Clinical Biochemistry Laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes","volume":"115","author":"Morrow","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0080","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2013.06.050","article-title":"Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality","volume":"62","author":"Bjurman","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0085","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1161\/CIRCULATIONAHA.111.023697","article-title":"How to interpret elevated cardiac troponin levels","volume":"124","author":"Mahajan","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0090","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/eurheartj\/ehq446","article-title":"Cardiac imaging after myocardial infarction","volume":"32","author":"Flachskampf","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0095","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2967\/jnumed.106.038851","article-title":"Assessment of myocardial viability in patients with heart failure","volume":"48","author":"Schinkel","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0100","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1148\/rg.335125722","article-title":"MR imaging of myocardial infarction","volume":"33","author":"Rajiah","year":"2013","journal-title":"Radiographics"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0105","first-page":"655","article-title":"Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate","volume":"45","author":"Okada","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/1450-1147.103405","article-title":"(99m)Tc glucarate as a potential radiopharmaceutical agent for assessment of tumor viability: from bench to the bed side","volume":"11","author":"Choudhury","year":"2012","journal-title":"World J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.carres.2011.12.024","article-title":"Modifications in the nitric acid oxidation of D-glucose","volume":"350","author":"Smith","year":"2012","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0120","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.electacta.2014.02.128","article-title":"Controllable oxidation of glucose to gluconic acid and glucaric acid using an electrocatalytic reactor","volume":"130","author":"Bin","year":"2014","journal-title":"Electrochim Acta"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0125","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1016\/j.electacta.2009.11.041","article-title":"Improved preparative electrochemical oxidation of d-glucose to d-glucaric acid","volume":"55","author":"Ibert","year":"2010","journal-title":"Electrochim Acta"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0130","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0008-6215(02)00072-1","article-title":"Determination of the side-products formed during the nitroxide-mediated bleach oxidation of glucose to glucaric acid","volume":"337","author":"Ibert","year":"2002","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0135","first-page":"999","article-title":"Impact of animal handling on the results of 18F-FDG PET studies in mice","volume":"47","author":"Fueger","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nucmedbio.2010.08.002","article-title":"Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model","volume":"38","author":"Gambini","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0145","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.mnm.0000130243.06821.90","article-title":"99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice","volume":"25","author":"Liu","year":"2004","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0150","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/01.CIR.95.6.1577","article-title":"Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99mTc-labeled glucarate","volume":"95","author":"Narula","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0008-6363(97)00212-5","article-title":"Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system","volume":"37","author":"Grimm","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-5173(01)00922-X","article-title":"99mTc-glucarate for detection of isoproterenol-induced myocardial infarction in rats","volume":"233","author":"Arteaga de Murphy","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0165","first-page":"948","article-title":"Subcutaneous isoproterenol: a convenient rat model for early detection of myocardial necrosis","volume":"19","author":"Kung","year":"1978","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0170","first-page":"1503","article-title":"Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies","volume":"34","author":"Carrio","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0175","first-page":"808","article-title":"Subnuclear localization of Tc-99m glucarate in necrotic myocardium","volume":"37","author":"Rammohan","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0180","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1067\/mnc.2002.124479","article-title":"Indium 111 antimyosin and Tc-99m glucaric acid for noninvasive identification of oncotic and apoptotic myocardial necrosis","volume":"9","author":"Khaw","year":"2002","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nucmedbio.2017.12.006_bb0185","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1161\/CIRCULATIONAHA.106.623652","article-title":"Implications of the failure to identify high-risk electrocardiogram findings for the quality of care of patients with acute myocardial infarction: results of the Emergency Department Quality in Myocardial Infarction (EDQMI) study","volume":"114","author":"Masoudi","year":"2006","journal-title":"Circulation"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805117302500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805117302500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:56:13Z","timestamp":1530147373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805117302500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":37,"alternative-id":["S0969805117302500"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2017.12.006","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging of isoproterenol-induced myocardial injury with 18F labeled fluoroglucaric acid in a rat model","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2017.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}